FGFR1 amplification drives the downstream activation of MAPK signaling in cancer cells. Treatment with FGFR inhibitors showed downstream inhibition and induction of apoptosis in FGFR1-amplified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback